Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B
about
Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain.Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytesVoltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathwayObscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-linePhosphorylation and ankyrin-G binding of the C-terminal domain regulate targeting and function of the ammonium transporter RhBGDysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node diseaseThe ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cellsTargeting and stability of Na/Ca exchanger 1 in cardiomyocytes requires direct interaction with the membrane adaptor ankyrin-BRevisiting ankyrin-InsP3 receptor interactions: ankyrin-B associates with the cytoplasmic N-terminus of the InsP3 receptorThe sigma receptor: evolution of the concept in neuropsychopharmacologyDefective interactions of protein partner with ion channels and transporters as alternative mechanisms of membrane channelopathiesIdentification and characterization of two ankyrin-B isoforms in mammalian heart.Structural basis for spectrin recognition by ankyrinInherited bradyarrhythmia: A diverse genetic backgroundMolecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytesTranslational mobility of the type 3 inositol 1,4,5-trisphosphate receptor Ca2+ release channel in endoplasmic reticulum membraneThe Na-K-ATPase and Calcium-Signaling MicrodomainsNovel Variant in the ANK2 Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT Syndrome.Inositol trisphosphate receptor Ca2+ release channels.Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.Defining new insight into atypical arrhythmia: a computational model of ankyrin-B syndromeAnkyrin-B protein in heart failure: identification of a new component of metazoan cardioprotection.Isoform specificity among ankyrins. An amphipathic alpha-helix in the divergent regulatory domain of ankyrin-b interacts with the molecular co-chaperone Hdj1/Hsp40.Weighing in on molecular anchors: the role of ankyrin polypeptides in human arrhythmia.Ankyrin-G and beta2-spectrin collaborate in biogenesis of lateral membrane of human bronchial epithelial cells.Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac diseaseAlternative splicing: a key mechanism for ankyrin-B functional diversity?Cardiac ankyrins in health and diseaseCoordinating electrical activity of the heart: ankyrin polypeptides in human cardiac disease.N-cadherin haploinsufficiency affects cardiac gap junctions and arrhythmic susceptibility.Mechanisms of human arrhythmia syndromes: abnormal cardiac macromolecular interactions.Regulation of the ankyrin-B-based targeting pathway following myocardial infarctionEmerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.Dysfunction in ankyrin-based cellular pathways and human cardiac arrhythmia.Ankyrin protein networks in membrane formation and stabilization.Inositol 1,4,5-trisphosphate receptors and their protein partners as signalling hubs.Molecular Pathophysiology of Congenital Long QT Syndrome.A single divergent exon inhibits ankyrin-B association with the plasma membrane.Spatially defined InsP3-mediated signaling in embryonic stem cell-derived cardiomyocytes.Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.
P2860
Q24295272-59C1EEBF-2C55-4E31-8623-B765B99081E3Q24299734-614F20C7-2E0E-4673-A876-79ACF302F285Q24305894-1AEC3B51-F78E-4274-9126-C36865791720Q24311794-6C920EE1-3874-438E-8F58-1E89061819BCQ24314722-D97FF560-3CFA-4A33-A422-498CBC15E67CQ24318595-4A329DF6-3869-46CC-B9B7-51D0FACD307EQ24324183-AA06F06B-D264-49AC-944B-97B51CC41B06Q24337311-A3ADF60D-2E86-4792-B95F-877DE23ED24CQ24633422-AA1E2866-1F7E-43CF-971E-3240D32B74CCQ24651621-3198200B-2080-4FDB-A754-237527A3284BQ26866107-F565A571-E43E-4AEE-9354-ED209E1A7EC2Q27302084-DEAE4A0B-9F13-41AE-B6FD-AF03DD358972Q27659196-D49F80BF-F522-4FB7-8D7E-5E197146E107Q28071683-39A42426-E14F-4060-965F-A4D2ECA34577Q28505912-50CD0BFE-5278-4A02-B77C-EA50AC32417DQ28575512-75247345-5881-4B4F-8687-0E1E2926F735Q29543366-7F60C3B1-6DA6-4664-87F8-C9A8A980BB2BQ33168257-28E2F83E-A392-466D-A0C6-532D3D77ADA7Q33983069-5FDB158B-52E1-4AB1-BFA0-D28F8F7258AFQ34095165-9FDF7E05-4835-47FD-BB33-9B9304FED3FDQ34132568-C465F4A2-BF07-49D9-8AA8-FD3AC1FC9152Q34286967-1265F33C-33EA-47FA-92D5-4D8F4FEA7861Q34312369-FF20FA8A-0FCB-4093-B601-CC3ACBF41C16Q34558543-00294B89-29C3-4713-8CBB-260D10805FE1Q34577826-4B563B7C-17EA-4188-8F6E-86AA88233667Q34827043-A11DEA8A-7252-4EB5-A2D3-FCBF4C1FFF97Q34846699-1595A6EB-BF59-49DF-89AC-DA0A8149956FQ34977809-485BD810-25FB-40C5-8A98-9638DF78D960Q35195291-4EC2E89C-E81C-4CC0-AB69-D38B56A639C6Q36561910-3DB3CB7A-ABE5-45D9-B35C-64241B801E77Q36967654-116D5BDF-C48F-433F-AD91-8CF54E68E1C4Q37096967-AB7692EF-F6E6-46DE-A38B-4826839771EDQ37125035-7EBB38FF-B7F9-4A03-8323-83CB1AEB6CB0Q37608496-98D84714-039F-4D23-AA3D-43B22BB411D0Q37617545-6BBDACF4-CDDA-4332-9DA7-7D4589BD8014Q38718031-62B13469-9C46-463F-83FC-E469A58CFE1CQ38997049-D893E4B7-3757-4789-AAA7-AAC52EEBADA2Q41017216-2F2D62F7-F712-4F31-BDDC-E37AF11884E2Q41856437-0A7BAD58-4728-49C9-9661-7583413E3716Q42247011-374A4F0C-A651-45FA-84F1-FB2793B6223B
P2860
Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B
description
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2004
@ast
im März 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/03/26)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/03/26)
@nl
наукова стаття, опублікована в березні 2004
@uk
name
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@ast
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@en
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@nl
type
label
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@ast
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@en
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@nl
prefLabel
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@ast
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@en
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@nl
P2093
P2860
P356
P1476
Inositol 1,4,5-trisphosphate r ...... res interaction with ankyrin-B
@en
P2093
Janis A. Hoffman
Jonathan Q. Davis
Lydia H. Davis
Peter J. Mohler
Peter Michaely
Vann Bennett
P2860
P304
12980–12987
P356
10.1074/JBC.M313979200
P407
P577
2004-03-26T00:00:00Z